The trademark application A was filed by Mercury Pharma Group Limited, a corporation established under the laws of the United Kingdom of Great Britain and Northern Ireland (the "Applicant"). The application was published for oppositions on October 24, 2023, and it was registered by office on January 31, 2024 without any oppositions.
The application was filed in English (German was selected as the second language).